678 related articles for article (PubMed ID: 36429080)
21. Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review.
Lei P; Bai T; Sun Y
Front Physiol; 2019; 10():139. PubMed ID: 30863316
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Xu Y; Li X; Cheng Y; Yang M; Wang R
FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
[TBL] [Abstract][Full Text] [Related]
23. Emerging Potential Therapeutic Targets of Ferroptosis in Skeletal Diseases.
Liu X; Wang T; Wang W; Liang X; Mu Y; Xu Y; Bai J; Geng D
Oxid Med Cell Longev; 2022; 2022():3112388. PubMed ID: 35941905
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the potential ferroptosis mechanism and multitemporal expression change of central ferroptosis-related genes in cardiac ischemia-reperfusion injury.
Wang Z; He Z; Xuan Q; Zhang Y; Xu J; Lin J; Li H; Chen W; Jiang T
Front Physiol; 2022; 13():934901. PubMed ID: 36091399
[TBL] [Abstract][Full Text] [Related]
25. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis.
Yamada N; Karasawa T; Wakiya T; Sadatomo A; Ito H; Kamata R; Watanabe S; Komada T; Kimura H; Sanada Y; Sakuma Y; Mizuta K; Ohno N; Sata N; Takahashi M
Am J Transplant; 2020 Jun; 20(6):1606-1618. PubMed ID: 31909544
[TBL] [Abstract][Full Text] [Related]
26. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis.
Sun Z; Wu J; Bi Q; Wang W
Stem Cell Res Ther; 2022 Jul; 13(1):297. PubMed ID: 35841017
[TBL] [Abstract][Full Text] [Related]
27. Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury.
Hosohata K; Harnsirikarn T; Chokesuwattanaskul S
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743026
[TBL] [Abstract][Full Text] [Related]
28. miR-124-3p delivered by exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells inhibits ferroptosis to attenuate ischemia-reperfusion injury in steatotic grafts.
Wu L; Tian X; Zuo H; Zheng W; Li X; Yuan M; Tian X; Song H
J Nanobiotechnology; 2022 Apr; 20(1):196. PubMed ID: 35459211
[TBL] [Abstract][Full Text] [Related]
29. Ferroptosis as an emerging target in inflammatory diseases.
Mao H; Zhao Y; Li H; Lei L
Prog Biophys Mol Biol; 2020 Sep; 155():20-28. PubMed ID: 32311424
[TBL] [Abstract][Full Text] [Related]
30. Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury.
Miyamoto HD; Ikeda M; Ide T; Tadokoro T; Furusawa S; Abe K; Ishimaru K; Enzan N; Sada M; Yamamoto T; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JACC Basic Transl Sci; 2022 Aug; 7(8):800-819. PubMed ID: 36061338
[TBL] [Abstract][Full Text] [Related]
31. Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury.
Pan Y; Wang X; Liu X; Shen L; Chen Q; Shu Q
Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358568
[TBL] [Abstract][Full Text] [Related]
32. The molecular mechanisms and potential drug targets of ferroptosis in myocardial ischemia-reperfusion injury.
Zhang CH; Yan YJ; Luo Q
Life Sci; 2024 Mar; 340():122439. PubMed ID: 38278348
[TBL] [Abstract][Full Text] [Related]
33. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic Approaches in Cardiovascular Diseases.
Chen Y; Li X; Wang S; Miao R; Zhong J
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771298
[TBL] [Abstract][Full Text] [Related]
34. Ferroptosis in inflammatory arthritis: A promising future.
Chang S; Tang M; Zhang B; Xiang D; Li F
Front Immunol; 2022; 13():955069. PubMed ID: 35958605
[TBL] [Abstract][Full Text] [Related]
35. Impact of Prolonged Mechanical Ventilation on Ferroptosis in Renal Ischemia/Reperfusion Injury in Rats.
Zhou F; Yang Y; Luo L; Chen Y; Luo Q; Chen J
Biomed Res Int; 2020; 2020():6097516. PubMed ID: 32185211
[TBL] [Abstract][Full Text] [Related]
36. Identification and verification of hub genes associated with ferroptosis in ischemia and reperfusion injury during renal transplantation.
Tang Q; Li J; Wang Y; Sun Q
Int Immunopharmacol; 2023 Jul; 120():110393. PubMed ID: 37279643
[TBL] [Abstract][Full Text] [Related]
37. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
[TBL] [Abstract][Full Text] [Related]
38. Molecular Mechanisms of Ferroptosis and Relevance to Cardiovascular Disease.
Xie LH; Fefelova N; Pamarthi SH; Gwathmey JK
Cells; 2022 Sep; 11(17):. PubMed ID: 36078133
[TBL] [Abstract][Full Text] [Related]
39. Phospholipid oxidation products in ferroptotic myocardial cell death.
Stamenkovic A; Pierce GN; Ravandi A
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H156-H163. PubMed ID: 31050558
[TBL] [Abstract][Full Text] [Related]
40. Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury.
Lillo-Moya J; Rojas-Solé C; Muñoz-Salamanca D; Panieri E; Saso L; Rodrigo R
Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33922912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
